Cargando…
Two progressed malignant phyllodes tumors of the breast harbor alterations in genes frequently involved in other advanced cancers
BACKGROUND: The genomic landscape of phyllodes tumors (PTs) of the breast is not well defined, especially in patients with advanced disease. To shed light on this topic, paired primary and progressed tumor samples from two patients with malignant PTs were subjected to next-generation sequencing (NGS...
Autores principales: | Reinisch, Mattea, Kuemmel, Sherko, Breit, Elisabeth, Theuerkauf, Ingo, Harrach, Hakima, Schindowski, Dorothea, Moka, Detlef, Bettstetter, Marcus, Bruzas, Simona, Chiari, Ouafaa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365991/ https://www.ncbi.nlm.nih.gov/pubmed/34399808 http://dx.doi.org/10.1186/s13023-021-01986-z |
Ejemplares similares
-
Next-Generation Sequencing-Directed Therapy in Patients with Metastatic Breast Cancer in Routine Clinical Practice
por: Bruzas, Simona, et al.
Publicado: (2021) -
Safety and effectiveness of sacituzumab govitecan in patients with metastatic triple-negative breast cancer in real-world settings: first observations from an interdisciplinary breast cancer centre in Germany
por: Reinisch, Mattea, et al.
Publicado: (2023) -
Gene signatures in patients with early breast cancer and relapse despite pathologic complete response
por: Bruzas, Simona, et al.
Publicado: (2022) -
Olaparib for metastatic breast cancer in a patient with a germline PALB2 variant
por: Kuemmel, Sherko, et al.
Publicado: (2020) -
Prognostic and predictive impact of gene expression in node‐positive early breast cancer patients receiving dose‐dense versus standard‐dose adjuvant chemotherapy
por: Reinisch, Mattea, et al.
Publicado: (2023)